Instituto de Diagnóstico S.A.

SNSE:INDISA Stock Report

Market Cap: CL$224.2b

Instituto de Diagnóstico Past Earnings Performance

Past criteria checks 2/6

Instituto de Diagnóstico's earnings have been declining at an average annual rate of -12.9%, while the Healthcare industry saw earnings growing at 16.8% annually. Revenues have been growing at an average rate of 10.8% per year. Instituto de Diagnóstico's return on equity is 6.6%, and it has net margins of 3%.

Key information

-12.9%

Earnings growth rate

-12.9%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate10.8%
Return on equity6.6%
Net Margin3.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

We Think That There Are Issues Underlying Instituto de Diagnóstico's (SNSE:INDISA) Earnings

Dec 10
We Think That There Are Issues Underlying Instituto de Diagnóstico's (SNSE:INDISA) Earnings

Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings

Jun 05
Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings

Recent updates

We Think That There Are Issues Underlying Instituto de Diagnóstico's (SNSE:INDISA) Earnings

Dec 10
We Think That There Are Issues Underlying Instituto de Diagnóstico's (SNSE:INDISA) Earnings

Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings

Jun 05
Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings

Slowing Rates Of Return At Instituto de Diagnóstico (SNSE:INDISA) Leave Little Room For Excitement

Sep 07
Slowing Rates Of Return At Instituto de Diagnóstico (SNSE:INDISA) Leave Little Room For Excitement

Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly

Aug 17
Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Instituto de Diagnóstico S.A. (SNSE:INDISA)

May 19
A Look At The Intrinsic Value Of Instituto de Diagnóstico S.A. (SNSE:INDISA)

Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly

Apr 16
Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly

Instituto de Diagnóstico (SNSE:INDISA) Will Will Want To Turn Around Its Return Trends

May 06
Instituto de Diagnóstico (SNSE:INDISA) Will Will Want To Turn Around Its Return Trends

Is Instituto de Diagnóstico S.A. (SNSE:INDISA) A Strong Dividend Stock?

Mar 23
Is Instituto de Diagnóstico S.A. (SNSE:INDISA) A Strong Dividend Stock?

Instituto de Diagnóstico S.A.'s (SNSE:INDISA) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?

Mar 02
Instituto de Diagnóstico S.A.'s (SNSE:INDISA) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?

Is Instituto de Diagnóstico (SNSE:INDISA) Using Too Much Debt?

Feb 09
Is Instituto de Diagnóstico (SNSE:INDISA) Using Too Much Debt?

Should We Be Excited About The Trends Of Returns At Instituto de Diagnóstico (SNSE:INDISA)?

Jan 25
Should We Be Excited About The Trends Of Returns At Instituto de Diagnóstico (SNSE:INDISA)?

Instituto de Diagnóstico's(SNSE:INDISA) Share Price Is Down 37% Over The Past Three Years.

Jan 07
Instituto de Diagnóstico's(SNSE:INDISA) Share Price Is Down 37% Over The Past Three Years.

Should You Use Instituto de Diagnóstico's (SNSE:INDISA) Statutory Earnings To Analyse It?

Dec 23
Should You Use Instituto de Diagnóstico's (SNSE:INDISA) Statutory Earnings To Analyse It?

What Kind Of Shareholders Own Instituto de Diagnóstico S.A. (SNSE:INDISA)?

Dec 06
What Kind Of Shareholders Own Instituto de Diagnóstico S.A. (SNSE:INDISA)?

Are Poor Financial Prospects Dragging Down Instituto de Diagnóstico S.A. (SNSE:INDISA Stock?

Nov 20
Are Poor Financial Prospects Dragging Down Instituto de Diagnóstico S.A. (SNSE:INDISA Stock?

Revenue & Expenses Breakdown

How Instituto de Diagnóstico makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SNSE:INDISA Revenue, expenses and earnings (CLP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24235,3157,08042,9140
30 Jun 24230,6385,37341,6230
31 Mar 24225,6273,46041,4400
31 Dec 23218,93414440,6880
30 Sep 23208,743-1,75440,7730
30 Jun 23200,65365137,9570
31 Mar 23193,8264,65834,6400
31 Dec 22191,28813,05032,5550
30 Sep 22191,91418,86730,0760
30 Jun 22192,56821,80530,4530
31 Mar 22190,22721,85028,6710
31 Dec 21188,54320,65028,2350
30 Sep 21181,91118,45926,7910
30 Jun 21168,99114,03525,3010
31 Mar 21149,2246,80424,7680
31 Dec 20139,3563,50123,9510
30 Sep 20132,9912,14024,0370
30 Jun 20136,8484,66123,8230
31 Mar 20148,68710,38324,9580
31 Dec 19150,18511,63024,5400
30 Sep 19152,07412,08124,5870
30 Jun 19151,18012,61324,2060
31 Mar 19147,85914,82023,5300
31 Dec 18145,41114,69523,7260
30 Sep 18143,49214,80924,2620
30 Jun 18141,36714,43524,0910
31 Mar 18140,18812,11523,9610
31 Dec 17138,35111,88823,3840
30 Sep 17135,53311,85021,7280
30 Jun 17133,50211,80321,8240
31 Mar 17129,98511,64621,6560
31 Dec 16128,30812,93420,9790
30 Sep 16126,47814,20920,0060
30 Jun 16122,92214,04919,0610
31 Mar 16120,25013,81618,3380
31 Dec 15116,94213,13217,6250
30 Sep 15112,66611,95817,6680
30 Jun 15108,73211,54517,0960
31 Mar 15105,76311,33216,8570
31 Dec 14103,62811,73016,6280
30 Sep 14100,96711,67316,0880
30 Jun 1498,04911,44615,5060
31 Mar 1495,30711,13814,7230
31 Dec 1392,29910,58813,8820

Quality Earnings: INDISA has high quality earnings.

Growing Profit Margin: INDISA became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: INDISA's earnings have declined by 12.9% per year over the past 5 years.

Accelerating Growth: INDISA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: INDISA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (15.6%).

Return on Equity

High ROE: INDISA's Return on Equity (6.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 22:40
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Instituto de Diagnóstico S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steffania MosqueraCrediCorp Capital
Daniel Velandia OcampoCrediCorp Capital